UBS Group AG - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 46 filers reported holding NEOS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$7,000
-61.1%
11,916
-55.1%
0.00%
Q2 2020$18,000
+200.0%
26,555
+244.2%
0.00%
Q1 2020$6,000
-25.0%
7,716
+52.9%
0.00%
Q4 2019$8,000
+166.7%
5,047
+152.1%
0.00%
Q3 2019$3,0002,002
+694.4%
0.00%
Q2 2019$0
-100.0%
252
-98.6%
0.00%
Q1 2019$47,000
+74.1%
18,133
+7.5%
0.00%
Q4 2018$27,000
+200.0%
16,870
+804.6%
0.00%
Q3 2018$9,000
-97.7%
1,865
-97.0%
0.00%
Q2 2018$386,000
-31.6%
61,807
-9.1%
0.00%
Q1 2018$564,000
-19.7%
67,977
-1.2%
0.00%
Q4 2017$702,000
+8.8%
68,834
-2.3%
0.00%
Q3 2017$645,000
-63.9%
70,462
-71.2%
0.00%
-100.0%
Q2 2017$1,789,000
+128.5%
244,978
+125.3%
0.00%
Q1 2017$783,000
+30.7%
108,714
+6.1%
0.00%
Q4 2016$599,000
+33.7%
102,438
+50.3%
0.00%
Q3 2016$448,000
+611.1%
68,159
+911.4%
0.00%
Q2 2016$63,000
+16.7%
6,739
+35.4%
0.00%
Q1 2016$54,000
+5.9%
4,978
+39.8%
0.00%
Q4 2015$51,000
-44.0%
3,561
-17.6%
0.00%
Q3 2015$91,0004,3210.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,858,889$7,337,0005.11%
Proxima Capital Management, LLC 170,294$257,0000.77%
SPHERA FUNDS MANAGEMENT LTD. 3,530,731$5,331,0000.44%
Nantahala Capital Management 4,610,000$6,961,0000.21%
Wealthstar Advisors, LLC 73,295$111,0000.07%
Alambic Investment Management, L.P. 51,733$78,0000.06%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$151,0000.05%
BCS Wealth Management 29,520$45,0000.03%
Allred Capital Management, LLC 24,995$37,742,0000.02%
ALGERT GLOBAL LLC 34,254$52,0000.02%
View complete list of NEOS THERAPEUTICS INC shareholders